We can't find the internet
Attempting to reconnect
Something went wrong
Hang in there while we get back on track
£119.01
This is the most expensive it has ever been. Walk away.
£119 today · previous high £119 · all-time low £118
Humana Biomarkers for Alzheimer's Disease Drug Development 2785
We'll watch every seller, every day. One email when your price arrives.
Price History & Forecast
Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.
Last 31 days · 31 data points (no recent data)
NEW HERE?
Amazon shows you one price. We show you all of them.
Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.
WHAT'S ON THIS PAGE
when this has been cheap or pricey
where the price is heading next
all-time high & low, recent range
name your number, we'll email you
Price Distribution
Price distribution over 31 days • 2 price levels
Price Analysis
Most common price: £119 (23 days, 74.2%)
Price range: £118 - £119
Price levels: 2 different prices over 31 days
Description
Key Features
This volume from Humana provides an up-to-date overview of technologies used to accelerate Alzheimer's disease drug development.
The text covers the latest advances in preclinical and clinical research regarding molecular mechanisms and therapeutic strategies.
Explore how digital biomarkers and advanced neuroimaging analysis are transforming the way clinical trials are performed.
Part of the highly successful Methods in Molecular Biology series, specifically volume 2785.
Product Specifications
- Brand
- Humana
- Format
- hardcover
- ASIN
- 1071637738
- Domain
- Amazon UK
- Release Date
- 02 March 2024
- Listed Since
- 14 December 2023
Barcode
No barcode data available
Similar Products You Might Like
Biomarkers for Preclinical Alzheimer’s Disease: 137 (Neuromethods, 137)
Humana
Computational and Experimental Studies in Alzheimer's Disease
CRC Press
Biomarkers for Preclinical Alzheimer’s Disease: 137 (Neuromethods, 137)
Humana
Drug Discovery Approaches for the Treatment of Neurodegenerative Disorders: Alzheimer's Disease
Elsevier
Pharmacological Mechanisms in Alzheimer's Therapeutics
Springer
Alzheimer's Disease Drug Development: Research and Development Ecosystem
Cambridge University Press
Molecular Biology of Alzheimer's Disease: Genes and Mechanisms Involved in Amyloid Generation
CRC Press
The End of Alzheimer's: The Brain and Beyond
Elsevier
Biomarkers for Alzheimer’s Disease Drug Development: 1750 (Methods in Molecular Biology, 1750)
Humana
Emerging Drugs and Targets for Alzheimer's Disease: Volume 1: Beta-Amyloid (Drug Discovery Series)
Royal Society of Chemistry
Emerging Drugs and Targets for Alzheimer's Disease: Volume 2: Neuronal Plasticity (Drug Discovery Series)
Royal Society of Chemistry
Clinical Diagnosis and Management of Alzheimer's Disease
CRC Press
Biomarkers for Early Diagnosis of Alzheimer's Disease
A New Era in Alzheimer's Research: Pathogenesis, Prevention, and Treatment
Elsevier
Multi-Factorial Approach as a Therapeutic Strategy for the Management of Alzheimer’s Disease
Springer
Price unavailable
Springer - Pharmacological Mechanisms in Alzheimer's Therapeutics
Springer
The Dementias: Diagnosis, Management, and Research
American Psychiatric Association Publishing
Alzheimer's Disease: Advances in Genetics, Molecular and Cellular Biology
Springer
The Handbook of Alzheimer's Disease and Other Dementias: 1 (Blackwell Handbooks of Behavioral Neuroscience)
Wiley
Alzheimer’s Disease II: 24 (Topics in Medicinal Chemistry, 24)
Springer
Immunotherapy and Biomarkers in Neurodegenerative Disorders (Methods in Pharmacology and Toxicology)
Humana
Systems Biology of Alzheimer's Disease: 1303 (Methods in Molecular Biology, 1303)
Humana
Alzheimer's Disease and Related Disorders: Etiology, Pathogenesis and Therapeutics
Wiley
Alzheimer’s Disease: Diagnosis and Treatment Guide
Springer